1. Abiraterone plus olaparib in prostate cancer: a new form of synthetic lethality?. Issue 7 (July 2018) Authors: Antonarakis, Emmanuel S Journal: Lancet oncology Issue: Volume 19:Issue 7(2018) Page Start: 860 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Androgen pathway resistance in prostate cancer and therapeutic implications. (July 2015) Authors: Maughan, Benjamin L; Antonarakis, Emmanuel S Journal: Expert opinion on pharmacotherapy Issue: Volume 16:Number 10(2015) Page Start: 1521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Androgen receptor splice variant 7 in castration‐resistant prostate cancer: Clinical considerations. (3rd June 2016) Authors: Bryce, Alan H; Antonarakis, Emmanuel S Journal: International journal of urology Issue: Volume 23:Number 8(2016) Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bipolar androgen therapy (BAT): A patient's guide. Issue 7 (31st March 2022) Authors: Denmeade, Samuel; Antonarakis, Emmanuel S; Markowski, Mark C Journal: Prostate Issue: Volume 82:Issue 7(2022) Page Start: 753 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study. Issue 1 (January 2018) Authors: Teply, Benjamin A; Wang, Hao; Luber, Brandon; Sullivan, Rana; Rifkind, Irina; Bruns, Ashley; Spitz, Avery; DeCarli, Morgan; Sinibaldi, Victoria; Pratz, Caroline F; Lu, Changxue; Silberstein, John L; Luo, Jun; Schweizer, Michael T; Drake, Charles G; Carducci, Michael A; Paller, Channing J; Antonar... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy‐naïve castration‐resistant prostate cancer: The Kyoto‐Baltimore collaboration. (28th April 2017) Authors: Terada, Naoki; Maughan, Benjamin L; Akamatsu, Shusuke; Kobayashi, Takashi; Yamasaki, Toshinari; Inoue, Takahiro; Kamba, Tomomi; Ogawa, Osamu; Antonarakis, Emmanuel S Journal: International journal of urology Issue: Volume 24:Number 6(2017) Page Start: 441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Inherited HSD3B1 polymorphisms and hormonal therapy resistance. Issue 10 (October 2016) Authors: Antonarakis, Emmanuel S Journal: Lancet oncology Issue: Volume 17:Issue 10(2016:Oct.) Page Start: 1347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types. Issue 3 (2nd March 2021) Authors: Brown, Landon C; Tucker, Matthew D; Sedhom, Ramy; Schwartz, Eric B; Zhu, Jason; Kao, Chester; Labriola, Matthew K; Gupta, Rajan T; Marin, Daniele; Wu, Yuan; Gupta, Santosh; Zhang, Tian; Harrison, Michael R; George, Daniel J; Alva, Ajjai; Antonarakis, Emmanuel S; Armstrong, Andrew J Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Predicting treatment response in castration-resistant prostate cancer: could androgen receptor variant-7 hold the key?. Issue 2 (February 2014) Authors: Antonarakis, Emmanuel S Journal: Expert review of anticancer therapy Issue: Volume 15:Issue 2(2015) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications. (August 2017) Authors: Terada, Naoki; Akamatsu, Shusuke; Kobayashi, Takashi; Inoue, Takahiro; Ogawa, Osamu; Antonarakis, Emmanuel S Journal: Therapeutic advances in medical oncology Issue: Volume 9:Number 8(2017) Page Start: 565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗